Dashboard
Manage Tickers

CDNACareDx, Inc.

Nasdaq caredx.com


$ 11.08 $ 0.88 (8.64 %)    

Thursday, 09-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 11.06
$ 10.15
$ 0.00 x 0
$ 11.09 x 400
$ 10.14 - $ 11.08
$ 4.80 - $ 12.93
1,909,531
na
594.64M
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-22-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 06-09-2017 03-31-2017 10-Q
30 04-21-2017 12-31-2016 10-K
31 11-15-2016 09-30-2016 10-Q
32 08-22-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-29-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-31-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

caredx-sees-fy24-revenue-274m-282m-vs-266955m-est
CareDx Sees FY24 Revenue $274M-$282M Vs $2...
05/09/2024 21:24:08

caredx-q1-2024-adj-eps-003-beats-021-estimate-sales-72049m-beat-63140m-estimate
CareDx Q1 2024 Adj EPS $(0.03) Beats $(0.2...
05/09/2024 21:03:09

CareDx (NASDAQ:CDNA) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.21) by 85....

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 20:31:07

craig-hallum-reiterates-buy-on-caredx-maintains-15-price-target
Craig-Hallum Reiterates Buy on CareDx, Mai...
05/09/2024 16:49:36

Craig-Hallum analyst Connor Chamberlain reiterates CareDx (NASDAQ:CDNA) with a Buy and maintains $15 price target.

craig-hallum-upgrades-caredx-to-buy-raises-price-target-to-15
Craig-Hallum Upgrades CareDx to Buy, Raise...
05/01/2024 17:18:10

Craig-Hallum analyst Alexander Nowak upgrades CareDx (NASDAQ:CDNA) from Hold to Buy and raises the price target from $12 to ...

why-amd-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why AMD Shares Are Trading Lower By Around...
05/01/2024 17:01:56

powell-industries-posts-upbeat-results-joins-a10-networks-garmin-dupont-and-other-big-stocks-moving-higher-on-wednesday
Powell Industries Posts Upbeat Results, Jo...
05/01/2024 14:27:48

stephens--co-reiterates-overweight-on-caredx-maintains-15-price-target
Stephens & Co. Reiterates Overweight on Ca...
04/17/2024 14:11:19

Stephens & Co. analyst Mason Carrico reiterates CareDx (NASDAQ:CDNA) with a Overweight and maintains $15 price target.

caredx-appoints-john-w-hanna-as-its-new-president-and-ceo-and-member-of-board-of-directors-effective-april-15-2024
CareDx Appoints John W. Hanna As Its New P...
04/16/2024 20:03:49

caredx-expects-2024-revenue-of-260m-274m-est-260618m
CareDx Expects 2024 Revenue Of $260M-$274M...
02/28/2024 21:36:46

recap-caredx-q4-earnings
Recap: CareDx Q4 Earnings
02/28/2024 21:15:10

caredx-q4-2023-adj-eps-017-beats-027-estimate-sales-6557m-beat-6366m-estimate
CareDx Q4 2023 Adj EPS $(0.17) Beats $(0.2...
02/28/2024 21:14:40

CareDx (NASDAQ:CDNA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.27) by 37....

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

earnings-outlook-for-caredx
Earnings Outlook For CareDx
02/27/2024 18:02:07

Core News & Articles
'CareDX Drops After Jury Votes In Favor Of...
01/26/2024 18:41:07

https://seekingalpha.com/news/4059239-caredx-drops-after-jury-votes-in-favor-of-natera-in-patent-fight?utm_source=bloomberg_st&...

Core News & Articles
Watching CareDx; Hearing Patent Case Lost ...
01/26/2024 18:29:11

caredx-expects-q4-preliminary-revenue-of-65m-66m-down-approximately-3-qq-est-6171m
CareDx Expects Q4 Preliminary Revenue Of $...
01/09/2024 12:11:03

Preliminary cash, cash equivalents, and marketable securities were approximately $235 million as of December 31, 2023.

caredx-expects-full-year-2023-revenue-of-279m-280m-which-is-above-the-high-end-of-guidance-est-27643m
CareDx Expects Full Year 2023 Revenue Of $...
01/09/2024 12:08:50

Preliminary revenue for the full year ended December 31, 2023, is expected to be between $279 million and $280 million, a decre...

Core News & Articles
Delaware Court Denies CareDx's Motion For ...
12/11/2023 17:53:34

Natera successfully achieves key objective for trial set to begin on Jan. 22ndNatera, Inc. (NASDAQ:NTRA), a global leader in ce...

stephens--co-upgrades-caredx-to-overweight-announces-10-price-target
Stephens & Co. Upgrades CareDx to Overweig...
11/09/2023 14:20:22

Stephens & Co. analyst Mason Carrico upgrades CareDx (NASDAQ:CDNA) from Equal-Weight to Overweight and announces $10 pri...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION